Exhibit 99.1
Amended Loan Schedule to Secured Promissory Note dated November 10, 2022
between Acura Pharmaceuticals, Inc. and Abuse Deterrent Pharma, LLC
| | | Date | | Principal | | | Aggregated Principal | |
| Original Secured Promissory Note | | 11/10/2022 | | $2,319,279 | | | $2,319,279 | |
| Additional loans to be included: | | | | | | | | |
| Loan #1 | | 12/22/2022 | | $ | 250,000 | | | $ | 2,569,279 | |
| Loan #2 | | 1/19/2023 | | $ | 250,000 | | | $ | 2,819,279 | |
| Loan #3 | | 2/22/2023 | | $ | 250,000 | | | $ | 3,069,279 | |
| Loan #4 | | 3/20/2023 | | $ | 250,000 | | | $ | 3,319,279 | |
| Loan #5 | | 5/19/2023 | | $ | 150,000 | | | $ | 3,469,279 | |
| Loan #6 | | 7/10/2023 | | $ | 200,000 | | | $ | 3,669,279 | |
| Loan #7 | | 7/28/2023 | | $ | 250,000 | | | $ | 3,919,279 | |
| Loan #8 | | 8/30/2023 | | $ | 250,000 | | | $ | 4,169,279 | |
| Loan #9 | | 10/11/2023 | | $ | 250,000 | | | $ | 4,419,279 | |
| Loan #10 | | 12/04/2023 | | $ | 250,000 | | | $ | 4,669,279 | |
| Loan #11 | | 1/08/2024 | | $ | 250,000 | | | $ | 4,919,279 | |
| Loan #12 | | 2/14/2024 | | $ | 250,000 | | | $ | 5,169,279 | |
| Loan #13 | | 3/14/2024 | | $ | 250,000 | | | $ | 5,419,279 | |
| Loan #14 | | 5/10/2024 | | $ | 200,000 | | | $ | 5,619,279 | |
| Loan #15 | | 6/03/2024 | | $ | 75,000 | | | $ | 5,694,279 | |
| Loan #16 | | 6/14/2024 | | $ | 200,000 | | | $ | 5,894,279 | |
| Loan #17 | | 7/03/2024 | | $ | 150,000 | | | $ | 6,044,279 | |
| Loan #18 | | 7/22/2024 | | $ | 100,000 | | | $ | 6,144,279 | |
| Loan #19 | | 8/19/2024 | | $ | 125,000 | | | $ | 6,269,279 | |
| Loan #20 | | 9/20/2024 | | $ | 100,000 | | | $ | 6,369,279 | |
| Loan #21 | | 9/30/2024 | | $ | 150,000 | | | $ | 6,519,279 | |
| Loan #22 | | 10/11/2024 | | $ | 100,000 | | | $ | 6,619,279 | |
| Loan #23 | | 10/28/2024 | | $ | 100,000 | | | $ | 6,719,279 | |
| Loan #24 | | 11/20/2024 | | $ | 100,000 | | | $ | 6,819,279 | |
| Loan #25 | | 11/27/2024 | | $ | 75,000 | | | $ | 6,894,279 | |
| Loan #26 | | 12/12/2024 | | $ | 50,000 | | | $ | 6,944,279 | |
ACURA PHARMACEUTICALS, INC.
By: /s/ Robert A. Seiser
Robert A. Seiser
Senior Vice President & CFO
Date: December 13, 2024
